David Perez-Caballero

Title: David Perez-Caballero: Innovator in Antibody Development

Introduction

David Perez-Caballero is a notable inventor based in Briarwood, NY (US). He has made significant contributions to the field of biotechnology, particularly in the development of human antibodies targeting respiratory syncytial virus (RSV). His work is crucial in advancing therapeutic options for viral infections.

Latest Patents

David holds 2 patents related to his innovative research. His latest patents include fully human antibodies that bind to the respiratory syncytial virus F protein. These antibodies are designed to prevent the fusion of the virus with the cell membrane, thereby inhibiting cell-to-cell spread of the virus. This invention provides a means of preventing RSV infection and treating patients suffering from the infection, while also ameliorating symptoms or complications associated with the viral infection. Additionally, these antibodies may be useful for diagnosing RSV infections.

Career Highlights

David Perez-Caballero is currently employed at Regeneron Pharmaceuticals, Inc., where he continues to work on groundbreaking research in the field of immunology. His expertise in antibody development has positioned him as a key player in the fight against viral infections.

Collaborations

Throughout his career, David has collaborated with esteemed colleagues such as Anne Gurnett-Bander and Sumathi Sivapalasingam. These collaborations have further enhanced the impact of his research and innovations.

Conclusion

David Perez-Caballero is a prominent inventor whose work in developing human antibodies against respiratory syncytial virus has the potential to transform treatment options for patients. His contributions to biotechnology are invaluable and continue to pave the way for future innovations in the field.